The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
In vivo tissue-tropism of adeno-associated viral vectors
Open accessAbstract
In this review, a brief account of the historical perspective of the discovery of the first cellular receptor and co-receptor of the prototype adeno-associated virus serotype 2 (AAV2) will be presented. The Subsequent discovery of a number of AAV serotypes, and attempts to identify the cellular receptors and co-receptors for these serotype vectors has had significant implications in their use in human gene therapy. As additional AAV serotypes are discovered and isolated, a detailed understanding of their tropism is certainly likely to play a key role in all future studies, both basic science as well as clinical.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Manno, C. S., Pierce, G. F., Arruda, V. R., Glader, B., Ragni, M., Rasko, J. J. E., Ozelo, M. C., Hoots, K., Blatt, P., Konkle, B., et al. (2006) · Nature Medicine · doi:10.1038/nm1358 · Cited by 2,163
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Effect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
Nathwani, A. C., Tuddenham, E. G. D., Rangarajan, S., Rosales, C., McIntosh, J., Linch, D. C., Chowdary, P., Riddell, A., Pie, A. J., Harrington, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108046 · Cited by 1,864
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520
Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
Zincarelli, C., Soltys, S., Rengo, G., & Rabinowitz, J. E. (2008) · Molecular Therapy · doi:10.1038/mt.2008.76 · Cited by 1,490
Summerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,406
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
Nathwani, A. C., Reiss, U. M., Tuddenham, E. G. D., Rosales, C., Chowdary, P., McIntosh, J., Della Peruta, M., Lheriteau, E., Patel, N., Raj, D., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407309 · Cited by 1,273
Gene therapy clinical trials worldwide to 2012 – an update
Ginn, S. L., Alexander, I. E., Edelstein, M. L., Abedi, M. R., & Wixon, J. (2013) · The Journal of Gene Medicine · doi:10.1002/jgm.2698 · Cited by 1,159
Kaplitt, M. G., Leone, P., Samulski, R. J., Xiao, X., Pfaff, D. W., O'Malley, K. L., & During, M. J. (1994) · Nature Genetics · doi:10.1038/ng1094-148 · Cited by 1,031
Adenovirus-Associated Defective Virus Particles
Atchison, R. W., Casto, B. C., & Hammon, W. M. (1965) · Science · doi:10.1126/science.149.3685.754 · Cited by 1,004
Hauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954
Adeno-associated Virus Serotypes: Vector Toolkit for Human Gene Therapy
Wu, Z., Asokan, A., & Samulski, R. J. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.009 · Cited by 922
MacLaren, R. E., Groppe, M., Barnard, A. R., Cottriall, C. L., Tolmachova, T., Seymour, L., Clark, K. R., During, M. J., Cremers, F. P. M., Black, G. C. M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62117-0 · Cited by 796
AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B
Manno, C. S., Chew, A. J., Hutchison, S., Larson, P. J., Herzog, R. W., Arruda, V. R., Tai, S. J., Ragni, M. V., Thompson, A., Ozelo, M., et al. (2003) · Blood · doi:10.1182/blood-2002-10-3296 · Cited by 749
αVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection
Summerford, C., Bartlett, J. S., & Samulski, R. J. (1999) · Nature Medicine · doi:10.1038/4768 · Cited by 711
Cideciyan, A. V., Aleman, T. S., Boye, S. L., Schwartz, S. B., Kaushal, S., Roman, A. J., Pang, J.-J., Sumaroka, A., Windsor, E. A. M., Wilson, J. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807027105 · Cited by 673
Kessler, P. D., Podsakoff, G. M., Chen, X., McQuiston, S. A., Colosi, P. C., Matelis, L. A., Kurtzman, G. J., & Byrne, B. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14082 · Cited by 614
Snyder, R. O., Miao, C. H., Patijn, G. A., Spratt, S. K., Danos, O., Nagy, D., Gown, A. M., Winther, B., Meuse, L., Cohen, L. K., et al. (1997) · Nature Genetics · doi:10.1038/ng0797-270 · Cited by 579
Gene therapy vectors based on adeno-associated virus type 1
Xiao, W., Chirmule, N., Berta, S. C., McCullough, B., Gao, G., & Wilson, J. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3994-4003.1999 · Cited by 541
An essential receptor for adeno-associated virus infection
Pillay, S., Meyer, N. L., Puschnik, A. S., Davulcu, O., Diep, J., Ishikawa, Y., Jae, L. T., Wosen, J. E., Nagamine, C. M., Chapman, M. S., et al. (2016) · Nature · doi:10.1038/nature16465 · Cited by 532
Rutledge, E. A., Halbert, C. L., & Russell, D. W. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.309-319.1998 · Cited by 452
Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V., & Srivastava, A. (1999) · Nature Medicine · doi:10.1038/4758 · Cited by 443
Self-citationAkache, B., Grimm, D., Pandey, K., Yant, S. R., Xu, H., & Kay, M. A. (2006) · Journal of Virology · doi:10.1128/jvi.00878-06 · Cited by 430
Gaudet, D., Méthot, J., Déry, S., Brisson, D., Essiembre, C., Tremblay, G., Tremblay, K., de Wal, J., Twisk, J., van den Bulk, N., et al. (2013) · Gene Therapy · doi:10.1038/gt.2012.43 · Cited by 404
Binding of Adeno-associated Virus Type 5 to 2,3-Linked Sialic Acid Is Required for Gene Transfer
Walters, R. W., Yi, S. M. P., Keshavjee, S., Brown, K. E., Welsh, M. J., Chiorini, J. A., & Zabner, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101559200 · Cited by 363
Identification of PDGFR as a receptor for AAV-5 transduction
Pasquale, G. D., Davidson, B. L., Stein, C. S., Martins, I., Scudiero, D., Monks, A., & Chiorini, J. A. (2003) · Nature Medicine · doi:10.1038/nm929 · Cited by 355
Flotte, T. R., Trapnell, B. C., Humphries, M., Carey, B., Calcedo, R., Rouhani, F., Campbell-Thompson, M., Yachnis, A. T., Sandhaus, R. A., McElvaney, N. G., et al. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.053 · Cited by 335
Wu, Z., Miller, E., Agbandje-McKenna, M., & Samulski, R. J. (2006) · Journal of Virology · doi:10.1128/jvi.00895-06 · Cited by 328
Terminal N-Linked Galactose Is the Primary Receptor for Adeno-associated Virus 9
Shen, S., Bryant, K. D., Brown, S. M., Randell, S. H., & Asokan, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.210922 · Cited by 282
Flotte, T., Carter, B., Conrad, C., Guggino, W., Reynolds, T., Rosenstein, B., Taylor, G., Walden, S., & Wetzel, R. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.9-1145 · Cited by 279
Gene transfer into the mouse retina mediated by an adeno-associated viral vector
Ali, R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.5.591 · Cited by 255
Hepatocyte Growth Factor Receptor Is a Coreceptor for Adeno-Associated Virus Type 2 Infection
Kashiwakura, Y., Tamayose, K., Iwabuchi, K., Hirai, Y., Shimada, T., Matsumoto, K., Nakamura, T., Watanabe, M., Oshimi, K., & Daida, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.609-614.2005 · Cited by 246
Gene Therapy for Aromatic l -Amino Acid Decarboxylase Deficiency
Hwu, W.-L., Muramatsu, S.-I., Tseng, S.-H., Tzen, K.-Y., Lee, N.-C., Chien, Y.-H., Snyder, R. O., Byrne, B. J., Tai, C.-H., & Wu, R.-M. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003640 · Cited by 246
Koeberl, D. D., Alexander, I. E., Halbert, C. L., Russell, D. W., & Miller, A. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1426 · Cited by 246
Mori, S., Wang, L., Takeuchi, T., & Kanda, T. (2004) · Virology · doi:10.1016/j.virol.2004.10.012 · Cited by 245
Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles
Chiorini, J. A., Yang, L., Liu, Y., Safer, B., & Kotin, R. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6823-6833.1997 · Cited by 231
Gene Therapy for Leber Hereditary Optic Neuropathy
Feuer, W. J., Schiffman, J. C., Davis, J. L., Porciatti, V., Gonzalez, P., Koilkonda, R. D., Yuan, H., Lalwani, A., Lam, B. L., & Guy, J. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2015.10.025 · Cited by 230
Adeno-associated virus 2 co-receptors?-first reply
Qing, K., Hansen, J., & Srivastava, A. (1999) · Nature Medicine · doi:10.1038/8526 · Cited by 228
Self-citationWagner, J. A., Messner, A. H., Moran, M. L., Daifuku, R., Kouyama, K., Desch, J. K., Manley, S., Norbash, A. M., Conrad, C. K., Friborg, S., et al. (1999) · The Laryngoscope · doi:10.1097/00005537-199902000-00017 · Cited by 210
Halbert, C. L., Standaert, T. A., Aitken, M. L., Alexander, I. E., Russell, D. W., & Miller, A. D. (1997) · Journal of Virology · doi:10.1128/jvi.71.8.5932-5941.1997 · Cited by 205
Monahan, P., Samulski, R., Tazelaar, J., Xiao, X., Nichols, T., Bellinger, D., Read, M., & Walsh, C. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300548 · Cited by 202
Adeno-Associated Virus 2 Infection Requires Endocytosis through the CLIC/GEEC Pathway
Nonnenmacher, M., & Weber, T. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.10.014 · Cited by 198
Conrad, C., Allen, S. S., Afione, S. A., Reynolds, T. C., Beck, S. E., Fee-Maki, M., Barraza-Ortiz, X., Adams, R. J., Askin, F. B., Carter, B. J., et al. (1996) · PubMed · Cited by 196
Asokan, A., Hamra, J. B., Govindasamy, L., Agbandje-McKenna, M., & Samulski, R. J. (2006) · Journal of Virology · doi:10.1128/jvi.00843-06 · Cited by 183
Duan, D., Yue, Y., Yan, Z., McCray, P. B., & Engelhardt, J. F. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.18-2761 · Cited by 171
Lalwani, A. K., Walsh, B., Reilly, P. G., Muzyczka, N., & Mhatre, A. N. (1996) · PubMed · Cited by 169
Scalable Purification of Adeno-Associated Virus Type 2, 4, or 5 Using Ion-Exchange Chromatography
Kaludov, N., Handelman, B., & Chiorini, J. A. (2002) · Human Gene Therapy · doi:10.1089/104303402320139014 · Cited by 167
Schmidt, M., Voutetakis, A., Afione, S., Zheng, C., Mandikian, D., & Chiorini, J. A. (2008) · Journal of Virology · doi:10.1128/jvi.02012-07 · Cited by 165
Nucleotide Sequencing and Generation of an Infectious Clone of Adeno-Associated Virus 3
Muramatsu, S.-I., Mizukami, H., Young, N. S., & Brown, K. E. (1996) · Virology · doi:10.1006/viro.1996.0367 · Cited by 159
Handa, A., Muramatsu, S., Qiu, J., Mizukami, H., & Brown, K. E. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-8-2077 · Cited by 148
Identification of the Galactose Binding Domain of the Adeno-Associated Virus Serotype 9 Capsid
Bell, C. L., Gurda, B. L., Vliet, K. V., Agbandje‐McKenna, M., & Wilson, J. M. (2012) · Journal of Virology · doi:10.1128/jvi.00448-12 · Cited by 143
Epidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6
Weller, M. L., Amornphimoltham, P., Schmidt, M., Wilson, P. A., Gutkind, J. S., & Chiorini, J. A. (2010) · Nature Medicine · doi:10.1038/nm.2145 · Cited by 140
Bantel-Schaal, U., Delius, H., Schmidt, R., & zur Hausen, H. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.939-947.1999 · Cited by 128
Ponnazhagan, S., Mukherjee, P., Yöder, M. C., Wang, X.-S., Zhou, S. Z., Kaplan, J. M., Wadsworth, S. C., & Srivastava, A. (1997) · Gene · doi:10.1016/s0378-1119(96)00576-8 · Cited by 125
Self-citationAdeno-associated virus vector-mediated transduction in the cat brain
Vite, C. H., Passini, M. A., Haskins, M. E., & Wolfe, J. H. N. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302087 · Cited by 117
Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid
Vercauteren, K., Hoffman, B. E., Zolotukhin, I., Keeler, G. D., Xiao, J. W., Basner-Tschakarjan, E., High, K. A., Ertl, H. C., Rice, C. M., Srivastava, A., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.61 · Cited by 114
Self-citationWang, L., Bell, P. L., Somanathan, S., Wang, Q., He, Z., Yu, H., McMenamin, D., Goode, T. L., Calcedo, R., & Wilson, J. M. (2015) · Molecular Therapy · doi:10.1038/mt.2015.179 · Cited by 113
Chen, S., Kapturczak, M., Loiler, S., Zolotukhin, S., Glushakova, O. Y., Madsen, K., Samulski, R. J., Hauswirth, W. W., Campbell‐Thompson, M., Berns, K. I., et al. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.235 · Cited by 112
rAAV vector-mediated sarcogylcan gene transfer in a hamster model for limb girdle muscular dystrophy
Li, J., Dressman, D. C., Tsao, Y., Sakamoto, A., Hoffman, E. P., & Xiao, X. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300830 · Cited by 112
Ling, C., Lu, Y., Kalsi, J. K., Jayandharan, G. R., Li, B., Ma, W., Cheng, B., Gee, S. W. Y., McGoogan, K. E., Govindasamy, L., et al. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.075 · Cited by 107
Self-citationAdeno-Associated Virus Type 2 Binds to a 150-Kilodalton Cell Membrane Glycoprotein
Mizukami, H., Young, N. S., & Brown, K. E. (1996) · Virology · doi:10.1006/viro.1996.0099 · Cited by 105
Adeno-Associated Virus Types 5 and 6 Use Distinct Receptors for Cell Entry
Seiler, M. P., Miller, A. D., Zabner, J., & Halbert, C. L. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.10 · Cited by 104
Corti, M., Cleaver, B. D., Clément, N., Conlon, T. J., Faris, K. J., Wang, G., Benson, J. M., Tarantal, A. F., Fuller, D., Herzog, R. W., et al. (2015) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2015.068 · Cited by 102
Molecular Characterization of Adeno-Associated Viruses Infecting Children
Chen, C., Jensen, R. L., Schnepp, B. C., Connell, M. J., SHELL, R. D., Sferra, T. J., Bartlett, J. S., Clark, K. R., & Johnson, P. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.23.14781-14792.2005 · Cited by 100
Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics
Voutetakis, A., Kok, M. R., Zheng, C., Bossis, I., Wang, J., Cotrim, A. P., Marracino, N., Goldsmith, C. M., Chiorini, J. A., Loh, Y. P., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400136101 · Cited by 94
Secreted and Transmembrane Mucins Inhibit Gene Transfer with AAV4 More Efficiently than AAV5
Walters, R. W., Pilewski, J. M., Chiorini, J. A., & Zabner, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200292200 · Cited by 86
Custom Adeno-Associated Virus Capsids: The Next Generation of Recombinant Vectors with Novel Tropism
Muzyczka, N., & Warrington, K. H. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.408 · Cited by 84
Li, S., Ling, C., Li, Z., Li, M., Su, Q., He, R., Tang, Q., Greiner, D. L., Shultz, L. D., Brehm, M. A., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.174 · Cited by 82
Self-citationBoye, S. L., Bennett, A., Scalabrino, M. L., McCullough, K. T., Van Vliet, K., Choudhury, S., Ruan, Q., Peterson, J., Agbandje-McKenna, M., & Boye, S. E. (2016) · Journal of Virology · doi:10.1128/jvi.00200-16 · Cited by 79
Shimazaki, K., Urabe, M., Monahan, J., OZAWA, K., & Kawai, N. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301211 · Cited by 79
Schmidt, M., Lakshmanan Govindasamy, A., Afione, S. A., Kaludov, N., Agbandje‐McKenna, M., & Chiorini, J. A. (2008) · Journal of Virology · doi:10.1128/jvi.00672-08 · Cited by 74
Ponnazhagan, S., Yöder, M. C., & Srivastava, A. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.3098-3104.1997 · Cited by 72
Self-citationPonnazhagan, S., Wang, X.-S., Woody, M. J., Luo, F., Kang, L. Y., Nallari, M. L., Munshi, N. C., Zhou, S. Z., & Srivastava, A. (1996) · Journal of General Virology · doi:10.1099/0022-1317-77-6-1111 · Cited by 64
Self-citationAttachment of adeno-associated virus type 3H to fibroblast growth factor receptor 1
Blackburn, S. D., Steadman, R., & Johnson, F. B. (2005) · Archives of Virology · doi:10.1007/s00705-005-0650-6 · Cited by 57
Byrne, B. J., Smith, B. K., Mah, C. S., Lawson, L. A., Islam, S., Corti, M., Martin, D., Dobija, N., Irwin, M. V., Conlon, T. J., et al. (2014) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2014.2514 · Cited by 48
Kurzeder, C., Koppold, B., Sauer, G., Pabst, S., Kreienberg, R., & Deißler, H. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.2.325 · Cited by 48
CFTR gene transduction in neonatal rabbits using anadeno-associated virus (AAV) vector
Rubenstein, R. C., McVeigh, U., Flotte, T. R., Guggino, W. B., & Zeitlin, P. L. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300417 · Cited by 46
Adeno-associated virus vector mediated gene transfer to pancreatic beta cells
Prasad, K.-M. R., Yang, Z., Bleich, D., & Nadler, J. L. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301279 · Cited by 39
Polyak, S., Mah, C. S., Porvasnik, S., Herlihy, J.-D. H., Campbell‐Thompson, M., Byrne, B. J., & Valentine, J. F. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9991-1 · Cited by 39
Functional Analysis of the Putative Integrin Recognition Motif on Adeno-associated Virus 9
Shen, S., Berry, G. E., Rivera, R. M. C., Cheung, R., Troupes, A. N., Brown, S. M., Kafri, T., & Asokan, A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.608281 · Cited by 27
Mori, S., Takeuchi, T., Enomoto, Y., Kondo, K., Sato, K., Ono, F., Iwata, N., Sata, T., & Kanda, T. (2006) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2006.285 · Cited by 26
Adeno-Associated Virus: The Naturally Occurring Virus Versus the Recombinant Vector
Srivastava, A. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.29017.asr · Cited by 24
Self-citationLin, C.-Y., Ho, C.-H., Hsieh, Y.-H., & Kikuchi, T. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301672 · Cited by 21
Direct AAV-mediated gene delivery to the temporomandibular joint
Dai, J., & Rabie, A. B. M. (2006) · Frontiers in bioscience · doi:10.2741/2224 · Cited by 15
Gene Transfer an Unlikely Contributor to Patient's Death
Kaiser, J. (2007) · Science · doi:10.1126/science.318.5856.1535 · Cited by 14
Cited by
Goertsen, D., Flytzanis, N. C., Goeden, N., Chuapoco, M. R., Cummins, A., Chen, Y., Fan, Y., Zhang, Q., Sharma, J., Duan, Y., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-021-00969-4 · Cited by 420
Immunogenicity and toxicity of AAV gene therapy
Ertl, H. C. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.975803 · Cited by 402
AAV vectors: The Rubik’s cube of human gene therapy
Pupo, A., Fernández, A., Low, S. H., François, A., Suárez-Amarán, L., & Samulski, R. J. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.09.015 · Cited by 360
Therapies for rare diseases: therapeutic modalities, progress and challenges ahead
Tambuyzer, E., Vandendriessche, B., Austin, C. P., Brooks, P. J., Larsson, K., Miller Needleman, K. I., Valentine, J., Davies, K., Groft, S. C., Preti, R., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0049-9 · Cited by 357
Various AAV Serotypes and Their Applications in Gene Therapy: An Overview
Issa, S. S., Shaimardanova, A. A., Solovyeva, V. V., & Rizvanov, A. A. (2023) · Cells · doi:10.3390/cells12050785 · Cited by 313
Metadata
- Authors
- Srivastava, A.
- Venue
- Current Opinion in Virology
- Publisher
- Elsevier BV
- Published
- 2016-12
- Volume
- 21
- Pages
- 75-80
- ISSN
- 1879-6257 (ISSN-L)
- OpenAlex
- W2510758757
- Cited by
- 347
- References
- 86
- FWCI
- 3.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.